2013
DOI: 10.1002/jbm.a.34560
|View full text |Cite
|
Sign up to set email alerts
|

Functional evaluation of a novel vitreous substitute using polyethylene glycol sols injected into a foldable capsular vitreous body

Abstract: Polyethylene glycol (PEG) is a short-term (41 days) potential vitreous substitute and is too short for an ideal vitreous substitute. Previously, a foldable capsular vitreous body (FCVB) was designed to mimic vitreous function. The aim of this study is to evaluate whether PEG injected into FCVB can serve as a long-term vitreous substitute. In vitro study, a concentration of 5% (w/v) PEG sols showed natural-like mechanical and optical properties in terms of pH, density, light transmittance, refractive index, int… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
23
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
7
1
1

Relationship

2
7

Authors

Journals

citations
Cited by 23 publications
(23 citation statements)
references
References 30 publications
0
23
0
Order By: Relevance
“…Since 2008, there have been at least 20 publications on the FCVB, ranging from original design and in vitro mechanical testing to animal testing and human clinical trials. [124][125][126][127][128][129][130][131][132][133][134][135][136][137][138][139][140][141][142][143] While radically different from the natural vitreous humor as well as other hydrogel vitreous substitute designs, the FCVB has been shown to be a safe and effective vitreous substitute in humans over a 1-and 3-year observation period. With clinical trials currently underway in China, the FCVB is arguably closest to routine clinical use in humans compared to other experimental hydrogel vitreous substitutes.…”
Section: The Strive For Improved Vitreous Substitutes and Intraocularmentioning
confidence: 99%
“…Since 2008, there have been at least 20 publications on the FCVB, ranging from original design and in vitro mechanical testing to animal testing and human clinical trials. [124][125][126][127][128][129][130][131][132][133][134][135][136][137][138][139][140][141][142][143] While radically different from the natural vitreous humor as well as other hydrogel vitreous substitute designs, the FCVB has been shown to be a safe and effective vitreous substitute in humans over a 1-and 3-year observation period. With clinical trials currently underway in China, the FCVB is arguably closest to routine clinical use in humans compared to other experimental hydrogel vitreous substitutes.…”
Section: The Strive For Improved Vitreous Substitutes and Intraocularmentioning
confidence: 99%
“…FCVB have been approved in vitro and animal experiments [21][22][23]. Nevertheless, the clinical safety and efficacy of FCVB have not been verified yet, and previous associated clinical studies were not enough [18,19,24,25].…”
Section: Introductionmentioning
confidence: 99%
“…Due to the good retinal support provided by the FCVB, a study of the FCVB combined with a retinal prosthesis currently is in process. Results of FCVB combined with polyethylene glycol 30 and polyvinylalcohol hydrogel 31 have been reported. Based on this trial, a nine-center clinical trial (122 cases) is enrolling patients in China to further evaluate the efficacy and safety of the FCVB in human eyes.…”
Section: Discussionmentioning
confidence: 99%